CAAS Capital Management’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
2021
Q4
$771K Sell
2021
Q3
$1.57M Buy
2021
Q2
Sell
2021
Q1
$3.52M Buy